Alaway and Erythema Of Eyelid

This page shows results related to Alaway and Erythema Of Eyelid from the FDA Adverse Event Reporting System (AERS). The adverse event Erythema Of Eyelid has been reported to the FDA a total of 8 times for Alaway.

Learn More About Alaway Adverse Events

Safety Comparison of Erythema Of Eyelid in Alaway and Related Drugs

The Proportional Reporting Ratio (PRR) for Alaway and Erythema Of Eyelid is 122. The chart below compares this proportional reporting ratio of Erythema Of Eyelid for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Erythema Of Eyelid.

Erythema Of Eyelid

NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.

People Reporting Erythema Of Eyelid Used Alaway For the Following Reasons

Of those reporting Erythema Of Eyelid, why were they taking Alaway?

Eye Allergy
Eye Irritation
Drug Use For Unknown Indication
Eye Pruritus

Scientific Publications on Erythema Of Eyelid

Powered by Google